COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
Clinical trial NCT00654485 · COMPLETED
Trial details
- NCT number
- NCT00654485
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Enrollment
- 940
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.